Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Offen

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Neural Transmission. Supplementum|November 7, 2007
Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's diseaseD Offen, Y Barhum, Y S Levy, et al.
Archives of Virology|June 30, 1998
HTLV-1 in mouthwash cells from a TSP/HAM patient and asymptomatic carriersD Offen, A Achiron, L Wasserman, et al.
The Journal of Biological Chemistry|April 6, 2001
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathwaysD Daily, A Vlamis-Gardikas, D Offen, et al.
The Journal of Biological Chemistry|October 18, 2000
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1D Daily, A Vlamis-Gardikas, D Offen, et al.
Archives of Virology|January 1, 1996
Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriersA Achiron, O Pinhas-Hamiel, Y Barak, et al.
Journal of Molecular Neuroscience : MN|October 22, 2014
Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALSM Dadon-Nachum, K Ben-Yaacov, T Ben-Zur, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?I Ziv, D Offen, A Barzilai, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicityA Barzilai, R Zilkha-Falb, D Daily, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Therapeutic effect of myogenic cells modified to express neurotrophic factors in a rat model of sciatic nerve injuryM Dadon-Nachum, T Ben-Zur, I Srugo, et al.
Journal of Affective Disorders|January 23, 2016
The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeabilityF Ventorp, R Barzilay, S Erhardt, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Neural Transmission. Supplementum|November 7, 2007
Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's diseaseD Offen, Y Barhum, Y S Levy, et al.
Archives of Virology|June 30, 1998
HTLV-1 in mouthwash cells from a TSP/HAM patient and asymptomatic carriersD Offen, A Achiron, L Wasserman, et al.
The Journal of Biological Chemistry|April 6, 2001
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathwaysD Daily, A Vlamis-Gardikas, D Offen, et al.
The Journal of Biological Chemistry|October 18, 2000
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1D Daily, A Vlamis-Gardikas, D Offen, et al.
Archives of Virology|January 1, 1996
Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriersA Achiron, O Pinhas-Hamiel, Y Barak, et al.
Journal of Molecular Neuroscience : MN|October 22, 2014
Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALSM Dadon-Nachum, K Ben-Yaacov, T Ben-Zur, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?I Ziv, D Offen, A Barzilai, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicityA Barzilai, R Zilkha-Falb, D Daily, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Therapeutic effect of myogenic cells modified to express neurotrophic factors in a rat model of sciatic nerve injuryM Dadon-Nachum, T Ben-Zur, I Srugo, et al.
Journal of Affective Disorders|January 23, 2016
The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeabilityF Ventorp, R Barzilay, S Erhardt, et al.
Pageof 7